This feasibility study seeks to develop and pilot test Emotional Awareness and Expression Therapy as a possible treatment for people with prediabetes.
Prediabetes is a clinical condition in which hemoglobin A1C is between 5.6 and 6.4, and is usually associated with being overweight, poor diet, limited exercise, and psychological stress. This condition develops in to Type II diabetes in many people, and interventions to prevent such progression are needed. Because stress can directly negative impact blood glucose metabolism and can indirectly affect it through unhealthy behaviors (e.g., diet, exercise), it may be possible to reduce stress and improve clinical outcomes. Although most stress management approaches help people to calm their physiology and reduce their negative emotions, another approach to stress treatment is to help people disclose emotionally difficult experiences, become aware of and express their emotions, and change interpersonal relationships by becoming more assertive as well as more open/connected. Emotional Awareness and Expression Therapy (EAET) is an approach to stress reduction that uses these principles and it has been shown to be effective for somatic symptom disorders like chronic pain. In this study, we will adapt EAET to the prediabetes context and test its feasibility, acceptability and initial efficacy.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
16
Attempts to reduce stress and improve health behavior by engaging in emotional awareness and expression leading to changes in interpersonal relationships and health behavior
Wayne State University
Detroit, Michigan, United States
HbA1c
Hemoglobin A1c from venous blood
Time frame: Change from baseline to 3-month follow-up and 6-month follow-up
C-peptide
venous blood surrogate marker of insulin levels
Time frame: Change from baseline to 3-month follow-up and 6-month follow-up
Perceived Stress Scale
Psychological stress (scores from 0 to 40; higher scores indicate more perceived stress)
Time frame: Change from baseline to 3-month follow-up and 6-month follow-up
Body mass index
Measure of overweight / obesity
Time frame: Change from baseline to 3-month follow-up and 6-month follow-up
Health behavior
Self-reported exercise and diet over the past week
Time frame: Change from baseline to 3-month follow-up and 6-month follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.